Upcoming Events
Early Career Learning Pathway
The Early Career Learning Pathway offers a foundational overview of essential topics in obesity medicine. This pathway is designed to introduce key concepts and provide resources to support your learning and growth as you begin your journey in the field of Obesity Medicine.
Recent courses
This session will focus on the management of non-alcoholic fatty liver disease (NAFLD) with a particular emphasis on the role of GLP-1 agonists and SGLT-2 inhibitors in treating this condition.
|
In this session, Liz Paul will describe her experiences living with obesity, including her journey to overcoming internalized weight bias.
|
Obesity is a disease that disproportionately affects women. Those from ethnic/racial minorities and those who live in poverty are often more severely affected.
|
Pages
The material presented by the Obesity Medicine Association (OMA) is for educational purposes only. Opinions expressed do not necessarily reflect those of OMA. The material is not intended to represent the only or necessarily best method or procedure appropriate for the medical situations discussed. Instead, it is intended to present an approach, view, statement, or opinion of the faculty that may be helpful to others who face similar situations. The individual is responsible for becoming familiar with laws and prescribing limitations within his or her own state before practicing various therapies. OMA also presents a forum for its members to be exposed to various products and services. It is the responsibility of each attendee or member to do due diligence, including reviewing literature, lectures, and background information.
OMA disclaims any and all liability for injury or other damages resulting to any individual viewing pages on obesitymedicine.org or academy.obesitymedicine.org and for all claims that may arise out of the use of the techniques demonstrated therein by such individuals, whether these claims shall be asserted by physician or any other person.